KR20230058590A - 연어과 오일 조성물을 사용하는 호흡기 치료 - Google Patents

연어과 오일 조성물을 사용하는 호흡기 치료 Download PDF

Info

Publication number
KR20230058590A
KR20230058590A KR1020227038919A KR20227038919A KR20230058590A KR 20230058590 A KR20230058590 A KR 20230058590A KR 1020227038919 A KR1020227038919 A KR 1020227038919A KR 20227038919 A KR20227038919 A KR 20227038919A KR 20230058590 A KR20230058590 A KR 20230058590A
Authority
KR
South Korea
Prior art keywords
salmonid
acid
oil
less
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227038919A
Other languages
English (en)
Korean (ko)
Inventor
보미 프람로즈
Original Assignee
호프세드 바이오케어 에이에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호프세드 바이오케어 에이에스에이 filed Critical 호프세드 바이오케어 에이에스에이
Publication of KR20230058590A publication Critical patent/KR20230058590A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020227038919A 2020-04-07 2021-04-07 연어과 오일 조성물을 사용하는 호흡기 치료 Pending KR20230058590A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063006327P 2020-04-07 2020-04-07
US63/006,327 2020-04-07
US202063114960P 2020-11-17 2020-11-17
US63/114,960 2020-11-17
PCT/US2021/026193 WO2021207367A1 (en) 2020-04-07 2021-04-07 Respiratory treatments using salmonid oil compositions

Publications (1)

Publication Number Publication Date
KR20230058590A true KR20230058590A (ko) 2023-05-03

Family

ID=78007067

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227038919A Pending KR20230058590A (ko) 2020-04-07 2021-04-07 연어과 오일 조성물을 사용하는 호흡기 치료

Country Status (10)

Country Link
US (2) US20210315941A1 (https=)
EP (1) EP4132571B1 (https=)
JP (2) JP2023521665A (https=)
KR (1) KR20230058590A (https=)
CN (1) CN115427067A (https=)
AU (1) AU2021253849A1 (https=)
BR (1) BR112022019244A2 (https=)
CA (1) CA3173877A1 (https=)
ES (1) ES3058840T3 (https=)
WO (1) WO2021207367A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102860729B1 (ko) 2024-07-02 2025-09-16 순천향대학교 산학협력단 연어 가공 부산물 가수분해물을 유효성분으로 포함하는 피부 건강 증진용 조성물

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102804807B1 (ko) * 2024-07-31 2025-05-13 (주)아이엠엠글로벌 연어 오일 제조 방법 및 그것에 의해 제조된 연어 오일

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175501B1 (da) * 2002-12-02 2004-11-15 Green Earth Anlæg og fremgangsmåde til kontinuerlig hydrolyse af et proteinholdigt animalsk eller vegetabilsk råmateriale
KR101260533B1 (ko) * 2005-03-03 2013-05-06 가부시키가이샤 메이지 면역기능 조정제
WO2012087153A1 (en) * 2010-12-23 2012-06-28 Marine Bioproducts As Enrichment of marine oils with omega-3 polyunsaturated fatty acids by lipase-catalysed hydrolysis
RU2552929C1 (ru) * 2013-11-14 2015-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
MY205552A (en) * 2017-05-30 2024-10-25 Deciphera Pharmaceuticals Inc Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl ]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha
JP7424998B2 (ja) * 2018-06-20 2024-01-30 ホフセス バイオケア アーエスアー 魚タンパク質加水分解物粉末および医薬としての使用のための前記粉末を含む組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102860729B1 (ko) 2024-07-02 2025-09-16 순천향대학교 산학협력단 연어 가공 부산물 가수분해물을 유효성분으로 포함하는 피부 건강 증진용 조성물

Also Published As

Publication number Publication date
JP2025142093A (ja) 2025-09-29
BR112022019244A2 (pt) 2022-11-08
ES3058840T3 (en) 2026-03-13
EP4132571A1 (en) 2023-02-15
WO2021207367A1 (en) 2021-10-14
CA3173877A1 (en) 2021-10-14
AU2021253849A1 (en) 2022-09-22
EP4132571B1 (en) 2025-10-29
EP4132571A4 (en) 2024-01-17
EP4132571C0 (en) 2025-10-29
US20210315941A1 (en) 2021-10-14
JP2023521665A (ja) 2023-05-25
US20240269196A1 (en) 2024-08-15
CN115427067A (zh) 2022-12-02

Similar Documents

Publication Publication Date Title
US11931335B2 (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
US20240269196A1 (en) Respiratory treatments using salmonid oil compositions
WO2021143912A1 (zh) 无细胞脂肪提取液对脂肪肝及其并发症的治疗作用
WO2022089591A1 (zh) 氨基葡萄糖在制备治疗非酒精性脂肪性药物中的应用
Cvjetićanin et al. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice
Liang et al. Celastrol alleviates airway hyperresponsiveness and inflammation in obese asthma through mediation of alveolar macrophage polarization
KR20220094115A (ko) 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 대사질환 예방 또는 치료용 조성물
JP4556009B2 (ja) 抗炎症剤、アレルギー性疾患予防又は改善剤及び機能性食品
Liang et al. Short-chain fatty acids: promising therapeutic targets for respiratory syncytial virus infection
CN113768956B (zh) 无细胞脂肪提取液对巨噬细胞极化调节与疾病治疗的作用
US20240100047A1 (en) Composition and method for treating covid-19
CN116473979B (zh) 甲基巴多索隆在制备抑制呼吸道合胞病毒感染药物中的应用
HK40086292B (en) Salmonid oil compositions for use in the treatment of eosinophilic related inflammatory and respiratory conditions
HK40086292A (en) Salmonid oil compositions for use in the treatment of eosinophilic related inflammatory and respiratory conditions
CN110664829A (zh) 京尼平苷在制备抗肺纤维化药物中的应用
US11896603B2 (en) Oligosaccharide as therapeutic agent for alcohol associated liver disease
JP6914256B2 (ja) 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法
CN112972440B (zh) 麝香酮在制备防治抑郁症的药物中的用途
WO2022028375A1 (zh) 无细胞脂肪提取液对肺部疾病的治疗用途
JP2021147394A (ja) 牛樟芝の酒酔い解消及び／又はアルコール代謝増加に用いる用途
EP4523684A1 (en) Compositions comprising lipoxin-a4 and maresin-1, and uses thereof
CN101327249B (zh) 二羟基苯基乳酸在制备治疗败血症的药物中的应用
Byung-Sung et al. Effects of grain larvae extracts on hepatotoxicity and blood lipid in obese rats
Ramya et al. Effect of anti-inflammatory activity of Hellenia speciosa (L.) and Costus pictus (L.)
You et al. Standardized alkali-treated Euglena gracilis β-glucan mitigates PM2. 5-induced pulmonary and cerebral injury through NF-κB, NRF2, and CREB–BDNF–TrkB pathways

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20221107

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240405

Comment text: Request for Examination of Application